Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Heart failure (HF) is a chronic disease that has a strong impact on quality of life and is often accompanied by anxiety and depression symptoms that can contribute to poor treatment compliance. The overall management of heart failure is currently part of the recommendations and, alongside drug therapy and electrical devices that can be proposed, lifestyle changes (diet, physical activity) can help improve well-being. and perhaps patient prognosis. Yoga is an ancient practice, known to improve the emotional and physical well-being of individuals. There is no formal medical contraindication to this practice, which can be perfectly adapted to the patient's condition. However, very few patients with heart failure practice yoga. A few randomized trials with small numbers as well as the combined analysis of several studies have shown the benefit of yoga in heart failure. The main objective of the research is to demonstrate the improvement in the quality of life induced by the regular practice of yoga in the management of stabilized chronic heart failure patients. Secondly, we will evaluate the effectiveness of regular yoga practice on improving the clinical condition of chronic heart failure patients.

Eligibility criteria

Qualifiers

Patient ≥18 years old

Chronic heart failure patient defined by: Most recent LVEF ≤50% (regardless of measurement method)

Stabilized (last episode of acute heart failure dating back more than a month) in NYHA stage I to III dyspnoea, ambulatory, discharged from hospital for > 1 month

Drug treatment optimized according to the judgment of the investigator

Disqualifiers

Patients who have practiced yoga regularly (> once a month) in the six months prior to selection.

Current pregnancy / lactation

Etiology of heart failure: hypertrophic cardiomyopathy, restrictive heart disease or severe curable valve disease

Severe renal impairment GFR<25ml/min/1.73 m2 or on dialysis.

Trial design

Treatments tested in this trial

  • Yoga arm
  • storytelling activities

Treatment groups

66 Participants
are divided into 2 treatment groups